Sysco (NYSE: SYY) Q3 2026 results and $29.1B Jetro Restaurant Depot acquisition
Sysco Corporation delivered modest top-line growth but lower profit in its fiscal Q3 2026 while announcing a transformative acquisition. Quarterly sales rose to $20.5 billion, up 4.7% from a year earlier, driven by higher case volumes across U.S. and international foodservice operations. Gross profit grew 6.5%, but operating income fell 9.1% to $619 million as incentive compensation, restructuring, transformation projects, and acquisition-related costs increased. Net earnings declined 15.2% to $340 million, with diluted EPS down to $0.71. For the first 39 weeks, sales reached $62.4 billion, up 3.6%, while operating income slipped to $2.1 billion and net earnings to $1.2 billion.
Cash generation remained solid: Sysco produced $1.46 billion in operating cash flow over 39 weeks, boosting cash, cash equivalents and restricted cash to $2.06 billion and total assets to $28.0 billion. Total debt rose to $14.0 billion, and interest expense for the period increased 9.2% to $512 million. The company continued returning capital via dividends of $0.54 per share in the quarter and share repurchases of $200 million year-to-date, while basic shares outstanding declined to about 479 million.
Sysco also detailed a planned acquisition of Jetro Restaurant Depot for approximately $29.1 billion, including $21.6 billion in cash and 91.5 million Sysco shares, after which JRD holders are expected to own about 16% of Sysco. The cash portion is backed by a $19 billion bridge loan commitment and a new $3 billion delayed draw term loan facility, alongside future permanent financing. A new revolving credit facility will expand to $4.0–5.0 billion post-closing. The deal is targeted to close by Q3 fiscal 2027, subject to regulatory approval; failure to obtain clearance would trigger a $1.164 billion termination fee.
Positive
- None.
Negative
- None.
Insights
Sysco posts modest growth but takes on major JRD deal and financing.
Sysco grew Q3 2026 sales 4.7% to $20.5 billion, with gross profit up 6.5%. However, operating income fell 9.1% to $619 million and net earnings dropped 15.2% to $340 million, mainly from higher incentive pay, restructuring, and acquisition-related costs.
For the first 39 weeks, sales reached $62.4 billion and EBITDA was $2.8 billion, slightly below last year, while adjusted EBITDA edged up 1.2% to $3.0 billion. Cash from operations improved to $1.46 billion, supporting dividends and $200 million of buybacks despite total debt rising to about $14.0 billion.
The planned $29.1 billion acquisition of Jetro Restaurant Depot is the key strategic swing, adding a large U.S. cash-and-carry footprint. Financing relies on a $19 billion bridge loan facility, a $3 billion delayed draw term loan, and future permanent debt and equity. A $1.164 billion break fee if regulators block the deal underscores execution and regulatory risk. Subsequent filings and closing progress will clarify leverage, interest cost, and integration impact.
Key Figures
Key Terms
bridge loan facility financial
cash flow hedges financial
net investment hedges financial
adjusted EBITDA financial
Certain Items financial
delayed draw term loan facility financial
(Mark One) | |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | ||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
☑ | Accelerated Filer | ☐ | |
Non-accelerated Filer | ☐ | Smaller Reporting Company | |
(Do not check if a smaller reporting company) | Emerging growth company |
PART I – FINANCIAL INFORMATION | Page No. | |
Item 1. | Financial Statements | 1 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 32 |
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 57 |
Item 4. | Controls and Procedures | 58 |
PART II – OTHER INFORMATION | ||
Item 1. | Legal Proceedings | 59 |
Item 1A. | Risk Factors | 59 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 60 |
Item 3. | Defaults Upon Senior Securities | 61 |
Item 4. | Mine Safety Disclosures | 61 |
Item 5. | Other Information | 61 |
Item 6. | Exhibits | 61 |
Signatures | 64 |
Mar. 28, 2026 | Jun. 28, 2025 | ||
(unaudited) | |||
ASSETS | |||
Current assets | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable, less allowances of $ | |||
Inventories | |||
Prepaid expenses and other current assets | |||
Income tax receivable | |||
Total current assets | |||
Plant and equipment at cost, less accumulated depreciation | |||
Other long-term assets | |||
Goodwill | |||
Intangibles, less amortization | |||
Deferred income taxes | |||
Operating lease right-of-use assets, net | |||
Other assets | |||
Total other long-term assets | |||
Total assets | $ | $ | |
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
Current liabilities | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued income taxes | |||
Current operating lease liabilities | |||
Current maturities of long-term debt | |||
Total current liabilities | |||
Long-term liabilities | |||
Long-term debt | |||
Deferred income taxes | |||
Long-term operating lease liabilities | |||
Other long-term liabilities | |||
Total long-term liabilities | |||
Noncontrolling interest | |||
Shareholders’ equity | |||
Preferred stock, par value $ | |||
Common stock, par value $ | |||
Paid-in capital | |||
Retained earnings | |||
Accumulated other comprehensive loss | ( | ( | |
Treasury stock at cost, | ( | ( | |
Total shareholders’ equity | |||
Total liabilities and shareholders’ equity | $ | $ | |
13-Week Period Ended | 39-Week Period Ended | ||||||
Mar. 28, 2026 | Mar. 29, 2025 | Mar. 28, 2026 | Mar. 29, 2025 | ||||
Sales | $ | $ | $ | $ | |||
Cost of sales | |||||||
Gross profit | |||||||
Operating expenses | |||||||
Operating income | |||||||
Interest expense | |||||||
Other expense (income), net | |||||||
Earnings before income taxes | |||||||
Income taxes | |||||||
Net earnings | $ | $ | $ | $ | |||
Net earnings: | |||||||
Basic earnings per share | $ | $ | $ | $ | |||
Diluted earnings per share | |||||||
Average shares outstanding | |||||||
Diluted shares outstanding | |||||||
13-Week Period Ended | 39-Week Period Ended | ||||||
Mar. 28, 2026 | Mar. 29, 2025 | Mar. 28, 2026 | Mar. 29, 2025 | ||||
Net earnings | $ | $ | $ | $ | |||
Other comprehensive income (loss): | |||||||
Foreign currency translation adjustment | ( | ( | |||||
Items presented net of tax: | |||||||
Amortization of cash flow hedges | |||||||
Change in net investment hedges | ( | ( | |||||
Change in cash flow hedges | ( | ||||||
Change in excluded components of fair value hedge | ( | ||||||
Amortization of actuarial loss | |||||||
Net actuarial gain and other adjustments arising in current year | |||||||
Change in marketable securities | ( | ||||||
Total other comprehensive income (loss) | |||||||
Comprehensive income | $ | $ | $ | $ | |||
Accumulated Other Comprehensive Loss | |||||||||||||||
Common Stock | Paid-in Capital | Retained Earnings | Treasury Stock | ||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||
Balance as of December 27, 2025 | $ | $ | $ | $( | $( | $ | |||||||||
Net earnings | |||||||||||||||
Other comprehensive income (loss) | |||||||||||||||
Dividends declared ($ | ( | ( | |||||||||||||
Treasury stock purchases | ( | ( | |||||||||||||
Share-based compensation awards | ( | ||||||||||||||
Adjustments to redeemable non-controlling interest | ( | ( | |||||||||||||
Balance as of March 28, 2026 | $ | $ | $ | $( | $( | $ | |||||||||
Accumulated Other Comprehensive Loss | |||||||||||||||
Common Stock | Paid-in Capital | Retained Earnings | Treasury Stock | ||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||
Balance as of December 28, 2024 | $ | $ | $ | $( | $( | $ | |||||||||
Net earnings | |||||||||||||||
Other comprehensive income (loss) | |||||||||||||||
Dividends declared ($ | ( | ( | |||||||||||||
Treasury stock purchases | ( | ( | |||||||||||||
Share-based compensation awards | ( | ( | |||||||||||||
Adjustments to redeemable non-controlling interest | ( | ( | |||||||||||||
Balance as of March 29, 2025 | $ | $ | $ | $( | $( | $ | |||||||||
Accumulated Other Comprehensive Loss | |||||||||||||||
Common Stock | Paid-in Capital | Retained Earnings | Treasury Stock | ||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||
Balance as of June 28, 2025 | $ | $ | $ | $( | $( | $ | |||||||||
Net earnings | |||||||||||||||
Other comprehensive income (loss) | |||||||||||||||
Dividends declared ($ | ( | ( | |||||||||||||
Treasury stock purchases | ( | ( | |||||||||||||
Share-based compensation awards | ( | ||||||||||||||
Adjustments to redeemable non-controlling interest | ( | ( | |||||||||||||
Balance as of March 28, 2026 | $ | $ | $ | $( | $( | $ | |||||||||
Accumulated Other Comprehensive Loss | |||||||||||||||
Common Stock | Paid-in Capital | Retained Earnings | Treasury Stock | ||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||
Balance as of June 29, 2024 | $ | $ | $ | $( | $( | $ | |||||||||
Net earnings | |||||||||||||||
Other comprehensive loss | |||||||||||||||
Dividends declared ($ | ( | ( | |||||||||||||
Treasury stock purchases | ( | ( | |||||||||||||
Share-based compensation awards | ( | ||||||||||||||
Adjustments to redeemable non-controlling interest | ( | ( | |||||||||||||
Balance as of March 29, 2025 | $ | $ | $ | $( | $( | $ | |||||||||
39-Week Period Ended | |||
Mar. 28, 2026 | Mar. 29, 2025 | ||
Cash flows from operating activities: | |||
Net earnings | $ | $ | |
Adjustments to reconcile net earnings to cash provided by operating activities: | |||
Share-based compensation expense | |||
Depreciation and amortization | |||
Operating lease asset amortization | |||
Amortization of debt issuance and other debt-related costs | |||
Deferred income taxes | ( | ( | |
Provision for losses on receivables | |||
Other non-cash items | ( | ( | |
Additional changes in certain assets and liabilities, net of effect of businesses acquired: | |||
Increase in receivables | ( | ( | |
Increase in inventories | ( | ( | |
Increase in prepaid expenses and other current assets | ( | ( | |
Increase (decrease) in accounts payable | ( | ||
Increase (decrease) in accrued expenses | ( | ||
Decrease in operating lease liabilities | ( | ( | |
Decrease in accrued income taxes | ( | ( | |
(Increase) decrease in other assets | ( | ||
(Decrease) increase in other long-term liabilities | ( | ||
Net cash provided by operating activities | |||
Cash flows from investing activities: | |||
Additions to plant and equipment | ( | ( | |
Proceeds from sales of plant and equipment | |||
Acquisition of businesses, net of cash acquired | ( | ( | |
Purchase of marketable securities | ( | ( | |
Proceeds from sales of marketable securities | |||
Other investing activities | |||
Net cash used for investing activities | ( | ( | |
Cash flows from financing activities: | |||
Bank and commercial paper borrowings (repayments), net | ( | ||
Other debt borrowings including senior notes | |||
Other debt repayments including senior notes | ( | ( | |
Proceeds from stock option exercises | |||
Stock repurchases | ( | ( | |
Dividends paid | ( | ( | |
Other financing activities | ( | ( | |
Net cash used for financing activities | ( | ( | |
Effect of exchange rates on cash, cash equivalents and restricted cash | ( | ( | |
Net increase in cash, cash equivalents and restricted cash | |||
Cash, cash equivalents and restricted cash at beginning of period | |||
Cash, cash equivalents and restricted cash at end of period | $ | $ | |
Supplemental disclosures of cash flow information: | |||
Cash paid during the period for: | |||
Interest | $ | $ | |
Income taxes, net of refunds (1) | |||
(1) | Cash paid for income taxes, net for the 39 weeks ended March 28, 2026 and March 29, 2025 includes $ of cash paid for the purchase of federal tax credits. | |||
Mar. 28, 2026 | Jun. 28, 2025 | ||
(In millions) | |||
Financed payment obligations | $ | $ | |
Mar. 28, 2026 | Mar. 29, 2025 | ||
(In millions) | |||
Cash and cash equivalents | $ | $ | |
Restricted cash (1) | |||
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows | $ | $ | |
(1) | Restricted cash primarily represents cash and cash equivalents of Sysco’s wholly owned captive insurance subsidiary, restricted for use to secure the insurer’s obligations for workers’ compensation, general liability and auto liability programs. Restricted cash is located within other assets in each consolidated balance sheet. |
Mar. 28, 2026 | Mar. 29, 2025 | ||
(In millions) | |||
Non-cash investing and financing activities: | |||
Plant and equipment acquired through financing programs | $ | $ | |
Assets obtained in exchange for finance lease obligations | |||
13-Week Period Ended Mar. 28, 2026 | ||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Principal Product Categories | ||||||||||
Fresh and frozen meats | $ | $ | $ | $ | $ | |||||
Canned and dry products | ||||||||||
Frozen fruits, vegetables, bakery and other | ||||||||||
Dairy products | ||||||||||
Poultry | ||||||||||
Fresh produce | ||||||||||
Paper and disposables | ||||||||||
Beverage products | ||||||||||
Seafood | ||||||||||
Equipment and smallwares | ||||||||||
Other (1) | ||||||||||
Total Sales | $ | $ | $ | $ | $ | |||||
(1) | Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies. |
13-Week Period Ended Mar. 29, 2025 | ||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Principal Product Categories | ||||||||||
Fresh and frozen meats | $ | $ | $ | $ | $ | |||||
Canned and dry products | ||||||||||
Frozen fruits, vegetables, bakery and other | ||||||||||
Dairy products | ||||||||||
Poultry | ||||||||||
Fresh produce | ||||||||||
Paper and disposables | ||||||||||
Beverage products | ||||||||||
Seafood | ||||||||||
Equipment and smallwares | ||||||||||
Other (1) | ||||||||||
Total Sales | $ | $ | $ | $ | $ | |||||
(1) | Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies. |
39-Week Period Ended Mar. 28, 2026 | ||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Principal Product Categories | ||||||||||
Fresh and frozen meats | $ | $ | $ | $ | $ | |||||
Canned and dry products | ||||||||||
Frozen fruits, vegetables, bakery and other | ||||||||||
Dairy products | ||||||||||
Poultry | ||||||||||
Fresh produce | ||||||||||
Paper and disposables | ||||||||||
Beverage products | ||||||||||
Seafood | ||||||||||
Equipment and smallwares | ||||||||||
Other (1) | ||||||||||
Total Sales | $ | $ | $ | $ | $ | |||||
(1) | Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies. |
39-Week Period Ended Mar. 29, 2025 | ||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Principal Product Categories | ||||||||||
Fresh and frozen meats | $ | $ | $ | $ | $ | |||||
Canned and dry products | ||||||||||
Frozen fruits, vegetables, bakery and other | ||||||||||
Dairy products | ||||||||||
Poultry | ||||||||||
Fresh produce | ||||||||||
Paper and disposables | ||||||||||
Beverage products | ||||||||||
Seafood | ||||||||||
Equipment and smallwares | ||||||||||
Other (1) | ||||||||||
Total Sales | $ | $ | $ | $ | $ | |||||
(1) | Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies. |
Assets Measured at Fair Value as of Mar. 28, 2026 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
(In millions) | |||||||
Assets: | |||||||
Cash and cash equivalents | $ | $ | $ | $ | |||
Restricted cash | |||||||
Total assets at fair value | $ | $ | $ | $ | |||
Assets Measured at Fair Value as of Jun. 28, 2025 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
(In millions) | |||||||
Assets: | |||||||
Cash and cash equivalents | $ | $ | $ | $ | |||
Restricted cash | |||||||
Total assets at fair value | $ | $ | $ | $ | |||
Mar. 28, 2026 | |||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||
(In millions) | |||||||||||
Fixed income securities: | |||||||||||
Corporate bonds | $ | $ | $( | $ | $ | $ | |||||
Government bonds | ( | ||||||||||
Total marketable securities | $ | $ | $( | $ | $ | $ | |||||
Jun. 28, 2025 | |||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||
(In millions) | |||||||||||
Fixed income securities: | |||||||||||
Corporate bonds | $ | $ | $( | $ | $ | $ | |||||
Government bonds | ( | ||||||||||
Total marketable securities | $ | $ | $( | $ | $ | $ | |||||
Mar. 28, 2026 | |
(In millions) | |
Due in one year or less | $ |
Due after one year through five years | |
Due after five years | |
Total | $ |
Maturity Date of the Hedging Instrument | Currency / Unit of Measure | Notional Value | ||
(In millions) | ||||
Hedging of interest rate risk | ||||
January 2034 | U.S. Dollar | |||
March 2035 | U.S. Dollar | |||
June 2031 | U.S. Dollar | |||
March 2036 | U.S. Dollar | |||
Hedging of foreign currency risk | ||||
January 2029 | Euro | |||
September 2030 | Canadian Dollar | |||
June 2031 | Canadian Dollar | |||
Hedging of fuel risk | ||||
Various (March 2026 to March 2028) | Gallons |
Derivative Fair Value | |||||
Balance Sheet location | Mar. 28, 2026 | Jun. 28, 2025 | |||
(In millions) | |||||
Fair Value Hedges: | |||||
Interest rate swaps | Prepaid expenses and other current assets | $ | $ | ||
Interest rate swaps | Other assets | ||||
Interest rate swaps | Accrued expenses | ||||
Interest rate swaps | Other long-term liabilities | ||||
Cash Flow Hedges: | |||||
Fuel swaps | Prepaid expenses and other current assets | $ | $ | ||
Fuel swaps | Other assets | ||||
Fuel swaps | Accrued expenses | ||||
Fuel swaps | Other long-term liabilities | ||||
Net Investment Hedges: | |||||
Cross currency swaps | Prepaid expenses and other current assets | $ | $ | ||
Cross currency swaps | Other assets | ||||
Cross currency swaps | Accrued expenses | ||||
Cross currency swaps | Other long-term liabilities | ||||
13-Week Period Ended | 39-Week Period Ended | |||||||
Mar. 28, 2026 | Mar. 29, 2025 | Mar. 28, 2026 | Mar. 29, 2025 | |||||
(In millions) | ||||||||
Total amounts of income and expense line items presented in the consolidated results of operations in which the effects of fair value hedges are recorded | $ | $ | $ | $ | ||||
Gain or (loss) on fair value hedging relationships: | ||||||||
Interest rate swaps: | ||||||||
Hedged items | $ | $( | $( | $( | ||||
Derivatives designated as hedging instruments | ( | ( | ||||||
Cross currency swaps and foreign currency forwards: | ||||||||
Hedged items | $ | $( | $ | $ | ||||
Derivatives designated as hedging instruments | ( | |||||||
13-Week Period Ended | 39-Week Period Ended | |||||||
Mar. 28, 2026 | Mar. 29, 2025 | Mar. 28, 2026 | Mar. 29, 2025 | |||||
(In millions) | ||||||||
Interest expense | $( | $( | $( | $( | ||||
(Increase) decrease in fair value of debt | ( | ( | ||||||
Foreign currency gain (loss) | ( | |||||||
Hedged items | $ | $( | $( | $( | ||||
13-Week Period Ended Mar. 28, 2026 | |||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||
(In millions) | (In millions) | ||||
Derivatives in cash flow hedging relationships: | |||||
Fuel swaps | $ | Operating expense | $ | ||
Derivatives in net investment hedging relationships: | |||||
Cross currency contracts | $ | N/A | $ | ||
13-Week Period Ended Mar. 29, 2025 | |||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||
(In millions) | (In millions) | ||||
Derivatives in cash flow hedging relationships: | |||||
Fuel swaps | $ | Operating expense | $ | ||
Derivatives in net investment hedging relationships: | |||||
Cross currency contracts | $( | N/A | $ | ||
39-Week Period Ended Mar. 28, 2026 | |||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||
(In millions) | (In millions) | ||||
Derivatives in cash flow hedging relationships: | |||||
Fuel swaps | $ | Operating expense | $( | ||
Derivatives in net investment hedging relationships: | |||||
Cross currency contracts | $ | N/A | $ | ||
39-Week Period Ended Mar. 29, 2025 | |||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||
(In millions) | (In millions) | ||||
Derivatives in cash flow hedging relationships: | |||||
Fuel swaps | $( | Operating expense | $ | ||
Foreign currency contracts | ( | Cost of sales / Other expense (income) | |||
Total | $( | $ | |||
Derivatives in net investment hedging relationships: | |||||
Cross currency contracts | $( | N/A | $ | ||
Derivatives in fair value hedging relationships: | |||||
Change in excluded component of fair value hedge | $( | Other expense (income) | $ | ||
Mar. 28, 2026 | |||
Carrying Amount of Hedged Assets (Liabilities) | Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Assets (Liabilities) | ||
(In millions) | |||
Balance sheet location: | |||
Long-term debt | $( | $ | |
Maturity Date | Par Value (In millions) | Coupon Rate | Pricing (percentage of par) | ||
July 25, 2031 (the 2031 Notes) | $ | ||||
March 25, 2036 (the 2036 Notes) |
13-Week Period Ended | 39-Week Period Ended | ||||||
Mar. 28, 2026 | Mar. 29, 2025 | Mar. 28, 2026 | Mar. 29, 2025 | ||||
(In millions, except for share and per share data) | (In millions, except for share and per share data) | ||||||
Numerator: | |||||||
Net earnings | $ | $ | $ | $ | |||
Denominator: | |||||||
Weighted-average basic shares outstanding | |||||||
Dilutive effect of share-based awards | |||||||
Weighted-average diluted shares outstanding | |||||||
Basic earnings per share | $ | $ | $ | $ | |||
Diluted earnings per share | $ | $ | $ | $ | |||
13-Week Period Ended Mar. 28, 2026 | |||||||
Location of Expense (Income) Recognized in Net Earnings | Before Tax Amount | Tax | Net of Tax Amount | ||||
(In millions) | |||||||
Foreign currency translation: | |||||||
Foreign currency translation adjustment | N/A | $( | $ | $( | |||
Hedging instruments: | |||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||
Change in cash flow hedges | Operating expenses | ||||||
Change in net investment hedges | N/A | ||||||
Total other comprehensive income before reclassification adjustments | |||||||
Reclassification adjustments: | |||||||
Amortization of cash flow hedges | Interest expense | ||||||
Reclassification adjustments: | |||||||
Amortization of actuarial loss, net | Other expense (income), net | ||||||
Total reclassification adjustments | |||||||
Marketable securities: | |||||||
Change in marketable securities | Other expense (income), net | ( | ( | ||||
Total other comprehensive income (loss) | $ | $ | $ | ||||
13-Week Period Ended Mar. 29, 2025 | |||||||
Location of Expense (Income) Recognized in Net Earnings | Before Tax Amount | Tax | Net of Tax Amount | ||||
(In millions) | |||||||
Foreign currency translation: | |||||||
Foreign currency translation adjustment | N/A | $ | $ | $ | |||
Hedging instruments: | |||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||
Change in cash flow hedges | Operating expenses | ||||||
Change in net investment hedges | N/A | ( | ( | ( | |||
Total other comprehensive income before reclassification adjustments | ( | ( | ( | ||||
Reclassification adjustments: | |||||||
Amortization of cash flow hedges | Interest expense | ||||||
Pension and other postretirement benefit plans: | |||||||
Reclassification adjustments: | |||||||
Amortization of actuarial loss, net | Other expense (income), net | ||||||
Total reclassification adjustments | |||||||
Marketable securities: | |||||||
Change in marketable securities | N/A | ||||||
Total other comprehensive income (loss) | $ | $ | $ | ||||
39-Week Period Ended Mar. 28, 2026 | |||||||
Location of Expense (Income) Recognized in Net Earnings | Before Tax Amount | Tax | Net of Tax Amount | ||||
(In millions) | |||||||
Foreign currency translation: | |||||||
Foreign currency translation adjustment | N/A | $( | $ | $( | |||
Hedging instruments: | |||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||
Change in cash flow hedges | Operating expenses | ||||||
Change in net investment hedges | N/A | ||||||
Total other comprehensive (loss) before reclassification adjustments | |||||||
Reclassification adjustments: | |||||||
Amortization of cash flow hedges | Interest expense | ||||||
Pension and other postretirement benefit plans: | |||||||
Other comprehensive income before reclassification adjustments: | |||||||
Net actuarial gain arising in the current year | |||||||
Reclassification adjustments: | |||||||
Amortization of actuarial loss, net | Other expense (income), net | ||||||
Total reclassification adjustments | |||||||
Total other comprehensive income (loss) | $ | $ | $ | ||||
39-Week Period Ended Mar. 29, 2025 | |||||||
Location of Expense (Income) Recognized in Net Earnings | Before Tax Amount | Tax | Net of Tax Amount | ||||
(In millions) | |||||||
Foreign currency translation: | |||||||
Foreign currency translation adjustment | N/A | $ | $ | $ | |||
Hedging instruments: | |||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||
Change in excluded component of fair value hedge | Other expense (income), net | ( | ( | ||||
Change in cash flow hedges | Operating expense | ( | ( | ( | |||
Change in net investment hedges | N/A | ( | ( | ( | |||
Total other comprehensive (loss) before reclassification adjustments | ( | ( | ( | ||||
Reclassification adjustments: | |||||||
Amortization of cash flow hedges | Interest expense | ||||||
Pension and other postretirement benefit plans: | |||||||
Other comprehensive income before reclassification adjustments: | |||||||
Net actuarial gain arising in the current year | |||||||
Reclassification adjustments: | |||||||
Amortization of actuarial loss, net | Other expense (income), net | ||||||
Total reclassification adjustments | |||||||
Marketable securities: | |||||||
Change in marketable securities | N/A | ||||||
Total other comprehensive income (loss) | $ | $ | $ | ||||
13-Week Period Ended Mar. 28, 2026 | |||||||||
Foreign Currency Translation | Hedging, net of tax | Pension and Other Postretirement Benefit Plans, net of tax | Marketable Securities, net of tax | Total | |||||
(In millions) | |||||||||
Balance as of Dec. 27, 2025 | $( | $( | $( | $ | $( | ||||
Equity adjustment from foreign currency translation | ( | — | — | — | ( | ||||
Amortization of cash flow hedges | — | — | — | ||||||
Change in net investment hedges | — | — | — | ||||||
Change in cash flow hedges | — | — | — | ||||||
Amortization of unrecognized net actuarial losses | — | — | — | ||||||
Change in marketable securities | — | — | — | ( | ( | ||||
Balance as of Mar. 28, 2026 | $( | $ | $( | $( | $( | ||||
13-Week Period Ended Mar. 29, 2025 | |||||||||
Foreign Currency Translation | Hedging, net of tax | Pension and Other Postretirement Benefit Plans, net of tax | Marketable Securities, net of tax | Total | |||||
(In millions) | |||||||||
Balance as of Dec. 28, 2024 | $( | $( | $( | $( | $( | ||||
Equity adjustment from foreign currency translation | — | — | — | ||||||
Amortization of cash flow hedges | — | — | — | ||||||
Change in net investment hedges | — | ( | — | — | ( | ||||
Change in cash flow hedges | — | — | — | ||||||
Amortization of unrecognized net actuarial losses | — | — | — | ||||||
Change in marketable securities | — | — | — | ||||||
Balance as of Mar. 29, 2025 | $( | $( | $( | $( | $( | ||||
39-Week Period Ended Mar. 28, 2026 | |||||||||
Foreign Currency Translation | Hedging, net of tax | Pension and Other Postretirement Benefit Plans, net of tax | Marketable Securities, net of tax | Total | |||||
(In millions) | |||||||||
Balance as of Jun. 28, 2025 | $( | $( | $( | $( | $( | ||||
Equity adjustment from foreign currency translation | ( | — | — | — | ( | ||||
Amortization of cash flow hedges | — | — | — | ||||||
Change in net investment hedges | — | — | — | ||||||
Change in cash flow hedges | — | — | — | ||||||
Amortization of unrecognized net actuarial losses | — | — | — | ||||||
Net actuarial loss arising in the current year | — | — | — | ||||||
Balance as of Mar. 28, 2026 | $( | $ | $( | $( | $( | ||||
39-Week Period Ended Mar. 29, 2025 | |||||||||
Foreign Currency Translation | Hedging, net of tax | Pension and Other Postretirement Benefit Plans, net of tax | Marketable Securities, net of tax | Total | |||||
(In millions) | |||||||||
Balance as of Jun. 29, 2024 | $( | $( | $( | $( | $( | ||||
Equity adjustment from foreign currency translation | — | — | — | ||||||
Amortization of cash flow hedges | — | — | — | ||||||
Change in net investment hedges | — | ( | — | — | ( | ||||
Change in cash flow hedges | — | ( | — | — | ( | ||||
Change in excluded component of fair value hedge | — | ( | — | — | ( | ||||
Amortization of unrecognized net actuarial losses | — | — | — | ||||||
Net actuarial gain arising in the current year | — | — | — | ||||||
Change in marketable securities | — | — | — | ||||||
Balance as of Mar. 29, 2025 | $( | $( | $( | $( | $( | ||||
13-Week Period Ended March 28, 2026 | ||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Sales | $ | $ | $ | $ | $ | |||||
Less: | ||||||||||
Cost of sales | ||||||||||
Operations expense | ||||||||||
Selling, general & administrative expense | ||||||||||
Total segment operating income | ||||||||||
Global Support Center | ( | |||||||||
Total operating income | ||||||||||
Interest expense | ||||||||||
Other expense (income), net | ||||||||||
Earnings before income taxes | $ | |||||||||
13-Week Period Ended March 29, 2025 | ||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Sales | $ | $ | $ | $ | $ | |||||
Less: | ||||||||||
Cost of sales | ||||||||||
Operations expense | ||||||||||
Selling, general & administrative expense | ||||||||||
Total segment operating income (loss) | ( | |||||||||
Global Support Center | ( | |||||||||
Total operating income | ||||||||||
Interest expense | ||||||||||
Other expense (income), net | ||||||||||
Earnings before income taxes | $ | |||||||||
39-Week Period Ended March 28, 2026 | ||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Sales | $ | $ | $ | $ | $ | |||||
Less: | ||||||||||
Cost of sales | ||||||||||
Operations expense | ||||||||||
Selling, general & administrative expense | ||||||||||
Total segment operating income | ||||||||||
Global Support Center | ( | |||||||||
Total operating income | ||||||||||
Interest expense | ||||||||||
Other expense (income), net | ||||||||||
Earnings before income taxes | $ | |||||||||
39-Week Period Ended March 29, 2025 | ||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||
(In millions) | ||||||||||
Sales | $ | $ | $ | $ | $ | |||||
Less: | ||||||||||
Cost of sales | ||||||||||
Operations expense | ||||||||||
Selling, general & administrative expense | ||||||||||
Total segment operating income | ||||||||||
Global Support Center | ( | |||||||||
Total operating income | ||||||||||
Interest expense | ||||||||||
Other expense (income), net | ||||||||||
Earnings before income taxes | $ | |||||||||
13-Week Period Ended | 13-Week Period Ended | |||
Mar. 28, 2026 | Mar. 29, 2025 | |||
Depreciation and amortization: | (In millions) | |||
U.S. Foodservice Operations | $ | $ | ||
International Foodservice Operations | ||||
SYGMA | ||||
Other | ||||
Total segments | ||||
Global Support Center | ||||
Total | $ | $ | ||
39-Week Period Ended | 39-Week Period Ended | |||
Mar. 28, 2026 | Mar. 29, 2025 | |||
Depreciation and amortization: | (In millions) | |||
U.S. Foodservice Operations | $ | $ | ||
International Foodservice Operations | ||||
SYGMA | ||||
Other | ||||
Total segments | ||||
Global Support Center | ||||
Total | $ | $ | ||
13-Week Period Ended | 13-Week Period Ended | |||
Mar. 28, 2026 | Mar. 29, 2025 | |||
Capital Expenditures: | (In millions) | |||
U.S. Foodservice Operations | $ | $ | ||
International Foodservice Operations | ||||
SYGMA | ||||
Other | ||||
Total segments | ||||
Global Support Center | ||||
Total | $ | $ | ||
39-Week Period Ended | 39-Week Period Ended | |||
Mar. 28, 2026 | Mar. 29, 2025 | |||
Capital Expenditures: | (In millions) | |||
U.S. Foodservice Operations | $ | $ | ||
International Foodservice Operations | ||||
SYGMA | ||||
Other | ||||
Total segments | ||||
Global Support Center | ||||
Total | $ | $ | ||
Mar. 28, 2026 | Jun. 28, 2025 | |||
Assets: | (In millions) | |||
U.S. Foodservice Operations | $ | $ | ||
International Foodservice Operations | ||||
SYGMA | ||||
Other | ||||
Total segments | ||||
Global Support Center | ||||
Total | $ | $ | ||
13-Week Period Ended | 39-Week Period Ended | ||||||
Mar. 28, 2026 | Mar. 29, 2025 | Mar. 28, 2026 | Mar. 29, 2025 | ||||
Sales | 100.0% | 100.0% | 100.0% | 100.0% | |||
Cost of sales | 81.4 | 81.7 | 81.6 | 81.8 | |||
Gross profit | 18.6 | 18.3 | 18.4 | 18.2 | |||
Operating expenses | 15.6 | 14.8 | 15.0 | 14.5 | |||
Operating income | 3.0 | 3.5 | 3.4 | 3.7 | |||
Interest expense | 0.8 | 0.8 | 0.8 | 0.8 | |||
Other expense (income), net | — | — | 0.1 | 0.1 | |||
Earnings before income taxes | 2.2 | 2.7 | 2.5 | 2.8 | |||
Income taxes | 0.5 | 0.7 | 0.6 | 0.6 | |||
Net earnings | 1.7% | 2.0% | 1.9% | 2.2% | |||
13-Week Period Ended | 39-Week Period Ended | ||
Mar. 28, 2026 | Mar. 28, 2026 | ||
Sales | 4.7% | 3.6% | |
Cost of sales | 4.3 | 3.4 | |
Gross profit | 6.5 | 4.8 | |
Operating expenses | 10.1 | 6.9 | |
Operating income | (9.1) | (4.0) | |
Interest expense | 12.8 | 9.2 | |
Other expense (income), net (1) (2) | (33.3) | 37.5 | |
Earnings before income taxes | (14.9) | (8.4) | |
Income taxes | (13.9) | (12.9) | |
Net earnings | (15.2)% | (7.0)% | |
Basic earnings per share | (13.4)% | (4.9)% | |
Diluted earnings per share | (13.4) | (4.9) | |
Average shares outstanding | (1.7) | (2.2) | |
Diluted shares outstanding | (1.7) | (2.3) |
(1) | Other expense (income), net was expense of $6 million and $9 million in the third quarter of fiscal 2026 and fiscal 2025, respectively. |
(2) | Other expense (income), net was expense of $44 million and $32 million in the first 39 weeks of fiscal 2026 and fiscal 2025, respectively. |
13-Week Period Ended Mar. 28, 2026 | |||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center | Consolidated Totals | ||||||
(In millions) | |||||||||||
Sales | $14,234 | $3,885 | $2,137 | $263 | $— | $20,519 | |||||
Sales increase | 3.1% | 12.4% | 2.5% | 2.3% | 4.7% | ||||||
Percentage of total | 69.4% | 18.9% | 10.4% | 1.3% | 100.0% | ||||||
Operating income (loss) | $772 | $83 | $18 | $7 | $(261) | $619 | |||||
Operating income (loss) increase (decrease) | 2.4% | (13.5)% | 5.9% | NM | 42.6% | (9.1)% | |||||
Percentage of total segments | 87.8% | 9.4% | 2.0% | 0.8% | 100.0% | ||||||
Operating income as a percentage of sales | 5.4% | 2.1% | 0.8% | 2.7% | 3.0% | ||||||
13-Week Period Ended Mar. 29, 2025 | |||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center | Consolidated Totals | ||||||
(In millions) | |||||||||||
Sales | $13,800 | $3,457 | $2,084 | $257 | $— | $19,598 | |||||
Percentage of total | 70.4% | 17.6% | 10.6% | 1.4% | 100.0% | ||||||
Operating income (loss) | $754 | $96 | $17 | $(3) | $(183) | $681 | |||||
Percentage of total segments | 87.2% | 11.1% | 2.0% | (0.3)% | 100.0% | ||||||
Operating income as a percentage of sales | 5.5% | 2.8% | 0.8% | (1.2)% | 3.5% | ||||||
39-Week Period Ended Mar. 28, 2026 | |||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center | Consolidated Totals | ||||||
(In millions) | |||||||||||
Sales | $43,397 | $11,851 | $6,392 | $789 | $— | $62,429 | |||||
Sales increase (decrease) | 2.8% | 8.0% | 2.3% | (1.6)% | 3.6% | ||||||
Percentage of total | 69.5% | 19.0% | 10.2% | 1.3% | 100.0% | ||||||
Operating income (loss) | $2,472 | $315 | $64 | $17 | $(756) | $2,112 | |||||
Operating income (loss) increase (decrease) | (1.0)% | 7.9% | 18.5% | 88.9% | 16.1% | (4.0)% | |||||
Percentage of total segments | 86.2% | 11.0% | 2.2% | 0.6% | 100.0% | ||||||
Operating income as a percentage of sales | 5.7% | 2.7% | 1.0% | 2.2% | 3.4% | ||||||
39-Week Period Ended Mar. 29, 2025 | |||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center | Consolidated Totals | ||||||
(In millions) | |||||||||||
Sales | $42,206 | $10,978 | $6,246 | $802 | $— | $60,232 | |||||
Percentage of total | 70.1% | 18.2% | 10.4% | 1.3% | 100.0% | ||||||
Operating income (loss) | $2,496 | $292 | $54 | $9 | $(651) | $2,200 | |||||
Percentage of total segments | 87.6% | 10.2% | 1.9% | 0.3% | 100.0% | ||||||
Operating income as a percentage of sales | 5.9% | 2.7% | 0.9% | 1.1% | 3.7% | ||||||
13-Week Period Ended Mar. 28, 2026 | 13-Week Period Ended Mar. 29, 2025 | Change in Dollars | % Change | ||||
(Dollars in millions) | |||||||
Sales | $14,234 | $13,800 | $434 | 3.1% | |||
Gross profit | 2,738 | 2,603 | 135 | 5.2 | |||
Operating expenses | 1,966 | 1,849 | 117 | 6.3 | |||
Operating income | $772 | $754 | $18 | 2.4% | |||
Gross profit | $2,738 | $2,603 | $135 | 5.2% | |||
Adjusted operating expenses (Non-GAAP) | 1,908 | 1,813 | 95 | 5.2 | |||
Adjusted operating income (Non-GAAP) | $830 | $790 | $40 | 5.1% | |||
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | % Change | ||||
(Dollars in millions) | |||||||
Sales | $43,397 | $42,206 | $1,191 | 2.8% | |||
Gross profit | 8,281 | 8,003 | 278 | 3.5 | |||
Operating expenses | 5,809 | 5,507 | 302 | 5.5 | |||
Operating income | $2,472 | $2,496 | $(24) | (1.0)% | |||
Gross profit | $8,281 | $8,003 | $278 | 3.5% | |||
Adjusted operating expenses (Non-GAAP) | 5,683 | 5,428 | 255 | 4.7 | |||
Adjusted operating income (Non-GAAP) | $2,598 | $2,575 | $23 | 0.9% | |||
Increase (Decrease) | Increase (Decrease) | ||||||
13-Week Period | 39-Week Period | ||||||
(Dollars in millions) | (Dollars in millions) | ||||||
Cause of change | Percentage | Dollars | Percentage | Dollars | |||
Case volume (1) | 2.3% | $315 | 1.0% | $442 | |||
Inflation | 0.6 | 84 | 1.6 | 673 | |||
Other | 0.2 | 35 | 0.2 | 76 | |||
Total change in sales | 3.1% | $434 | 2.8% | $1,191 | |||
(1) | Case volumes increased 2.3% and 1.0% compared to the third quarter and first 39 weeks of fiscal 2025, respectively. This volume increase resulted in a 2.3% and 1.0% increase in the dollar value of sales compared to the third quarter and first 39 weeks of fiscal 2025, respectively. |
13-Week Period Ended Mar. 28, 2026 | 13-Week Period Ended Mar. 29, 2025 | Change in Dollars | % Change | ||||
(Dollars in millions) | |||||||
Sales | $3,885 | $3,457 | $428 | 12.4% | |||
Gross profit | 834 | 728 | 106 | 14.6 | |||
Operating expenses | 751 | 632 | 119 | 18.8 | |||
Operating income | $83 | $96 | $(13) | (13.5)% | |||
Gross profit | $834 | $728 | $106 | 14.6% | |||
Adjusted operating expenses (Non-GAAP) | 690 | 600 | 90 | 15.0 | |||
Adjusted operating income (Non-GAAP) | $144 | $128 | $16 | 12.5% | |||
Sales on a constant currency basis (Non-GAAP) | $3,636 | $3,457 | $179 | 5.2% | |||
Gross profit on a constant currency basis (Non-GAAP) | 777 | 728 | 49 | 6.7 | |||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 640 | 600 | 40 | 6.7 | |||
Adjusted operating income on a constant currency basis (Non-GAAP) | $137 | $128 | $9 | 7.0% | |||
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | % Change | ||||
(Dollars in millions) | |||||||
Sales | $11,851 | $10,978 | $873 | 8.0% | |||
Gross profit | 2,492 | 2,262 | 230 | 10.2 | |||
Operating expenses | 2,177 | 1,970 | 207 | 10.5 | |||
Operating income | $315 | $292 | $23 | 7.9% | |||
Gross profit | $2,492 | $2,262 | $230 | 10.2% | |||
Adjusted operating expenses (Non-GAAP) | 2,039 | 1,875 | 164 | 8.7 | |||
Adjusted operating income (Non-GAAP) | $453 | $387 | $66 | 17.1% | |||
Sales on a constant currency basis (Non-GAAP) | $11,374 | $10,978 | $396 | 3.6% | |||
Gross profit on a constant currency basis (Non-GAAP) | 2,378 | 2,262 | 116 | 5.1 | |||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 1,937 | 1,875 | 62 | 3.3 | |||
Adjusted operating income on a constant currency basis (Non-GAAP) | $441 | $387 | $54 | 14.0% | |||
Increase (Decrease) | Increase (Decrease) | ||||||
13-Week Period | 39-Week Period | ||||||
(Dollars in millions) | (Dollars in millions) | ||||||
Cause of change | Percentage | Dollars | Percentage | Dollars | |||
Inflation | 3.6% | $125 | 4.1% | $447 | |||
Foreign currency | 7.2 | 249 | 4.3 | 477 | |||
Case volume | 1.0 | 36 | 1.4 | 162 | |||
Impact of divestiture | — | — | (1.9) | (207) | |||
Other | 0.6 | 18 | 0.1 | (6) | |||
Total change in sales | 12.4% | $428 | 8.0% | $873 | |||
The discussion of our results includes certain non-GAAP financial measures, including EBITDA and adjusted EBITDA, that we believe provide important perspective with respect to underlying business trends. Other than EBITDA and free cash flow, any non-GAAP financial measures will be denoted as adjusted measures to remove: (1) restructuring charges; (2) expenses associated with our various transformation initiatives; (3) severance charges; and (4) acquisition-related costs consisting of (a) intangible amortization expense and (b) acquisition costs and due diligence costs related to our acquisitions. Adjustments provided herein for fiscal 2026 results of operations also remove the impact of a charge associated with a legal matter. No similar charge was applicable in fiscal 2025. |
The results of our operations can be impacted due to changes in exchange rates applicable in converting local currencies to U.S. dollars. We measure our results on a constant currency basis. Constant currency operating results are calculated by translating current-period local currency operating results with the currency exchange rates used to translate the financial statements in the comparable prior-year period to determine what the current-period U.S. dollar operating results would have been if the currency exchange rate had not changed from the comparable prior-year period. We also measure our sales growth excluding the impact of our joint venture in Mexico which was divested in the second quarter of fiscal year 2025. |
Management believes that adjusting its operating expenses, operating income, operating margin, net earnings and diluted earnings per share to remove these Certain Items, presenting its results on a constant currency basis, and adjusting its sales results to exclude the impact of its joint venture in Mexico provides an important perspective with respect to our underlying business trends and results. It provides meaningful supplemental information to both management and investors that (1) is indicative of the performance of the company’s underlying operations and (2) facilitates comparisons on a year- over-year basis. |
Sysco has a history of growth through acquisitions and excludes from its non-GAAP financial measures the impact of acquisition-related intangible amortization, acquisition costs and due diligence costs for those acquisitions. We believe this approach significantly enhances the comparability of Sysco’s results for fiscal year 2026 and fiscal year 2025. |
Set forth on the following page is a reconciliation of sales, operating expenses, operating income, net earnings and diluted earnings per share to adjusted results for these measures for the periods presented. Individual components of diluted earnings per share may not be equal to the total presented when added due to rounding. Adjusted diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. |
13-Week Period Ended Mar. 28, 2026 | 13-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
Sales (GAAP) | $20,519 | $19,598 | $921 | 4.7% | |||
Impact of currency fluctuations (1) | (252) | (252) | (1.3) | ||||
Comparable sales using a constant currency basis (Non-GAAP) | $20,267 | $19,598 | $669 | 3.4% | |||
Cost of sales (GAAP) | $16,707 | $16,017 | $690 | 4.3% | |||
Gross profit (GAAP) | $3,812 | $3,581 | $231 | 6.5% | |||
Impact of currency fluctuations (1) | (58) | (58) | (1.7) | ||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $3,754 | $3,581 | $173 | 4.8% | |||
Gross margin (GAAP) | 18.58% | 18.27% | 31 bps | ||||
Impact of currency fluctuations (1) | (0.06) | -6 bps | |||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 18.52% | 18.27% | 25 bps | ||||
Operating expenses (GAAP) | $3,193 | $2,900 | $293 | 10.1% | |||
Impact of restructuring, transformational project, and other costs (2) | (94) | (50) | (44) | (88.0) | |||
Impact of acquisition-related costs (3) | (55) | (42) | (13) | (31.0) | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | 3,044 | 2,808 | 236 | 8.4 |
Impact of currency fluctuations (1) | (51) | (51) | (1.8) | ||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $2,993 | $2,808 | $185 | 6.6% | |||
Operating expense as a percentage of sales (GAAP) | 15.56% | 14.80% | 76 bps | ||||
Impact of certain item adjustments | (0.72) | (0.47) | -25 bps | ||||
Adjusted operating expense as a percentage of sales (Non- GAAP) | 14.84% | 14.33% | 51 bps | ||||
Operating income (GAAP) | $619 | $681 | $(62) | (9.1)% | |||
Impact of restructuring, transformational project, and other costs (2) | 94 | 50 | 44 | 88.0 | |||
Impact of acquisition-related costs (3) | 55 | 42 | 13 | 31.0 | |||
Operating income adjusted for Certain Items (Non-GAAP) | 768 | 773 | (5) | (0.6) | |||
Impact of currency fluctuations (1) | (7) | (7) | (1.0) | ||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $761 | $773 | $(12) | (1.6)% | |||
Operating margin (GAAP) | 3.02% | 3.47% | -45 bps | ||||
Operating margin adjusted for Certain Items (Non-GAAP) | 3.74% | 3.94% | -20 bps | ||||
Operating margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 3.75% | 3.94% | -19 bps | ||||
Net earnings (GAAP) | $340 | $401 | $(61) | (15.2)% | |||
Impact of restructuring, transformational project, and other costs (2) | 94 | 50 | 44 | 88.0 | |||
Impact of acquisition-related costs (3) | 55 | 42 | 13 | 31.0 | |||
Tax impact of restructuring, transformational project, and other costs (4) | (23) | (13) | (10) | (76.9) | |||
Tax impact of acquisition-related costs (4) | (14) | (11) | (3) | (27.3) | |||
Net earnings adjusted for Certain Items (Non-GAAP) | $452 | $469 | $(17) | (3.6)% | |||
Diluted earnings per share (GAAP) | $0.71 | $0.82 | $(0.11) | (13.4)% | |||
Impact of restructuring, transformational project, and other costs (2) | 0.20 | 0.10 | 0.10 | 100.0 | |||
Impact of acquisition-related costs (3) | 0.11 | 0.09 | 0.02 | 22.2 | |||
Tax impact of restructuring, transformational project, and other costs (4) | (0.05) | (0.03) | (0.02) | (66.7) | |||
Tax impact of acquisition-related costs (4) | (0.03) | (0.02) | (0.01) | (50.0) | |||
Diluted earnings per share adjusted for Certain Items (Non- GAAP) (5) | $0.94 | $0.96 | $(0.02) | (2.1)% |
(1) | Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on the current year results. |
(2) | Fiscal 2026 includes $43 million related to restructuring costs, severance charges, and costs associated with a legal matter and $51 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy. Fiscal 2025 includes $15 million related to restructuring and severance charges and $35 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy. |
(3) | Fiscal 2026 includes $42 million of intangible amortization expense and $13 million in acquisition and due diligence costs. Fiscal 2025 includes $32 million of intangible amortization expense and $10 million in acquisition and due diligence costs. |
(4) | The tax impact of adjustments for Certain Items are calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred. |
(5) | Individual components of diluted earnings per share may not equal the total presented when added due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. |
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
Sales (GAAP) | $62,429 | $60,232 | $2,197 | 3.6% | |||
Impact of Mexico joint venture sales | — | (207) | 207 | 0.4 | |||
Comparable sales excluding Mexico joint venture (Non-GAAP) | $62,429 | $60,025 | $2,404 | 4.0% | |||
Sales (GAAP) | $62,429 | $60,232 | $2,197 | 3.6% | |||
Impact of currency fluctuations (1) | (481) | (481) | (0.8) | ||||
Comparable sales using a constant currency basis (Non-GAAP) | $61,948 | $60,232 | $1,716 | 2.8% | |||
Cost of sales (GAAP) | $50,924 | $49,249 | $1,675 | 3.4% | |||
Gross profit (GAAP) | $11,505 | $10,983 | $522 | 4.8% | |||
Impact of currency fluctuations (1) | (115) | (115) | (1.1) | ||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $11,390 | $10,983 | $407 | 3.7% | |||
Gross margin (GAAP) | 18.43% | 18.23% | 20 bps | ||||
Impact of currency fluctuations (1) | (0.04) | -4 bps | |||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 18.39% | 18.23% | 16 bps | ||||
Operating expenses (GAAP) | $9,393 | $8,783 | $610 | 6.9% | |||
Impact of restructuring, transformational project, and other costs (2) | (207) | (107) | (100) | (93.5) | |||
Impact of acquisition-related costs (3) | (155) | (121) | (34) | (28.1) | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | 9,031 | 8,555 | 476 | 5.6 | |||
Impact of currency fluctuations (1) | (102) | (102) | (1.2) | ||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $8,929 | $8,555 | $374 | 4.4% | |||
Operating expense as a percentage of sales (GAAP) | 15.05% | 14.58% | 47 bps | ||||
Impact of certain item adjustments | (0.58) | (0.38) | -20 bps | ||||
Adjusted operating expense as a percentage of sales (Non- GAAP) | 14.47% | 14.20% | 27 bps | ||||
Operating income (GAAP) | $2,112 | $2,200 | $(88) | (4.0)% | |||
Impact of restructuring, transformational project, and other costs (2) | 207 | 107 | 100 | 93.5 | |||
Impact of acquisition-related costs (3) | 155 | 121 | 34 | 28.1 | |||
Operating income adjusted for Certain Items (Non-GAAP) | 2,474 | 2,428 | 46 | 1.9 | |||
Impact of currency fluctuations (1) | (13) | (13) | (0.5) | ||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $2,461 | $2,428 | $33 | 1.4% | |||
Operating margin (GAAP) | 3.38% | 3.65% | -27 bps | ||||
Operating margin adjusted for Certain Items (Non-GAAP) | 3.96% | 4.03% | -7 bps | ||||
Operating margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 3.97% | 4.03% | -6 bps | ||||
Net earnings (GAAP) | $1,206 | $1,297 | $(91) | (7.0)% | |||
Impact of restructuring, transformational project, and other costs (2) | 207 | 107 | 100 | 93.5 |
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
Impact of acquisition-related costs (3) | 155 | 121 | 34 | 28.1 | |||
Tax impact of restructuring, transformational project, and other costs (4) | (50) | (27) | (23) | (85.2) | |||
Tax impact of acquisition-related costs (4) | (37) | (31) | (6) | (19.4) | |||
Net earnings adjusted for Certain Items (Non-GAAP) | $1,481 | $1,467 | $14 | 1.0% | |||
Diluted earnings per share (GAAP) | $2.51 | $2.64 | $(0.13) | (4.9)% | |||
Impact of restructuring, transformational project, and other costs (2) | 0.43 | 0.22 | 0.21 | 95.5 | |||
Impact of acquisition-related costs (3) | 0.32 | 0.25 | 0.07 | 28.0 | |||
Tax impact of restructuring, transformational project, and other costs (4) | (0.10) | (0.05) | (0.05) | (100.0) | |||
Tax impact of acquisition-related costs (4) | (0.08) | (0.06) | (0.02) | (33.3) | |||
Diluted earnings per share adjusted for Certain Items (Non- GAAP) (5) | $3.08 | $2.98 | $0.10 | 3.4% |
(1) | Represents a constant currency adjustment which eliminates the impact of foreign currency fluctuations on the current year results. |
(2) | Fiscal 2026 includes $63 million related to restructuring costs, severance charges, and costs associated with a legal matter and $144 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy. Fiscal 2025 includes $31 million related to restructuring and severance charges and $76 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy. |
(3) | Fiscal 2026 includes $108 million of intangible amortization expense and $47 million in acquisition and due diligence costs. Fiscal 2025 includes $97 million of intangible amortization expense and $24 million in acquisition and due diligence costs. |
(4) | The tax impact of adjustments for Certain Items is calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred. |
(5) | Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. |
13-Week Period Ended Mar. 28, 2026 | 13-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
U.S. FOODSERVICE OPERATIONS | |||||||
Operating expenses (GAAP) | $1,966 | $1,849 | $117 | 6.3% | |||
Impact of restructuring, transformational project, and other costs (1) | (39) | (16) | (23) | NM | |||
Impact of acquisition-related costs (2) | (19) | (20) | 1 | 5.0 | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | $1,908 | $1,813 | $95 | 5.2% | |||
Operating income (GAAP) | $772 | $754 | $18 | 2.4% | |||
Impact of restructuring, transformational project, and other costs (1) | 39 | 16 | 23 | NM | |||
Impact of acquisition-related costs (2) | 19 | 20 | (1) | (5.0) | |||
Operating income adjusted for Certain Items (Non-GAAP) | $830 | $790 | $40 | 5.1% | |||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||
Sales (GAAP) | $3,885 | $3,457 | $428 | 12.4% | |||
Impact of currency fluctuations (3) | (249) | (249) | (7.2) | ||||
Comparable sales using a constant currency basis (Non-GAAP) | $3,636 | $3,457 | $179 | 5.2% | |||
Gross profit (GAAP) | $834 | $728 | $106 | 14.6% | |||
Impact of currency fluctuations (3) | (57) | (57) | (7.9) | ||||
Comparable gross profit using a constant currency basis (Non- GAAP) | $777 | $728 | $49 | 6.7% | |||
Gross margin (GAAP) | 21.47% | 21.06% | 41 bps | ||||
Impact of currency fluctuations (3) | (0.10) | -10 bps | |||||
Comparable gross margin using a constant currency basis (Non-GAAP) | 21.37% | 21.06% | 31 bps | ||||
Operating expenses (GAAP) | $751 | $632 | $119 | 18.8% | |||
Impact of restructuring and transformational project costs (4) | (39) | (13) | (26) | NM | |||
Impact of acquisition-related costs (2) | (22) | (19) | (3) | (15.8) | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | 690 | 600 | 90 | 15.0 | |||
Impact of currency fluctuations (3) | (50) | (50) | (8.3) | ||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $640 | $600 | $40 | 6.7% | |||
Operating income (GAAP) | $83 | $96 | $(13) | (13.5)% | |||
Impact of restructuring and transformational project costs (4) | 39 | 13 | 26 | NM | |||
Impact of acquisition-related costs (2) | 22 | 19 | 3 | 15.8 | |||
Operating income adjusted for Certain Items (Non-GAAP) | 144 | 128 | 16 | 12.5 | |||
Impact of currency fluctuations (3) | (7) | (7) | (5.5) | ||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $137 | $128 | $9 | 7.0% | |||
SYGMA | |||||||
Operating expenses (GAAP) | $145 | $149 | $(4) | (2.7)% | |||
Operating income (GAAP) | 18 | 17 | 1 | 5.9 | |||
OTHER | |||||||
Operating expenses (GAAP) | $61 | $63 | $(2) | (3.2)% | |||
Operating income (loss) (GAAP) | 7 | (3) | 10 | NM | |||
GLOBAL SUPPORT CENTER | |||||||
Gross profit (GAAP) | $9 | $24 | $(15) | (62.5)% | |||
13-Week Period Ended Mar. 28, 2026 | 13-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
Operating expenses (GAAP) | $270 | $207 | $63 | 30.4% | |||
Impact of restructuring and transformational project costs (5) | (16) | (21) | 5 | 23.8 | |||
Impact of acquisition-related costs (6) | (14) | (3) | (11) | NM | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | $240 | $183 | $57 | 31.1% | |||
Operating loss (GAAP) | $(261) | $(183) | $(78) | (42.6)% | |||
Impact of restructuring and transformational project costs (5) | 16 | 21 | (5) | (23.8) | |||
Impact of acquisition-related costs (6) | 14 | 3 | 11 | NM | |||
Operating loss adjusted for Certain Items (Non-GAAP) | $(231) | $(159) | $(72) | (45.3)% |
(1) | Primarily represents severance charges, transformation initiative costs, and costs associated with a legal matter. |
(2) | Fiscal 2026 and fiscal 2025 include intangible amortization expense and acquisition costs. |
(3) | Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results. |
(4) | Includes restructuring and transformation initiative costs primarily in Europe. |
(5) | Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy. |
(6) | Represents due diligence costs. |
NM | Represents that the percentage change is not meaningful. |
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
U.S. FOODSERVICE OPERATIONS | |||||||
Operating expenses (GAAP) | $5,809 | $5,507 | $302 | 5.5% | |||
Impact of restructuring, transformational project, and other costs (1) | (54) | (26) | (28) | NM | |||
Impact of acquisition-related costs (2) | (72) | (53) | (19) | (35.8) | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | $5,683 | $5,428 | $255 | 4.7% | |||
Operating income (GAAP) | $2,472 | $2,496 | $(24) | (1.0)% | |||
Impact of restructuring, transformational project, and other costs (1) | 54 | 26 | 28 | NM | |||
Impact of acquisition-related costs (2) | 72 | 53 | 19 | 35.8 | |||
Operating income adjusted for Certain Items (Non-GAAP) | $2,598 | $2,575 | $23 | 0.9% | |||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||
Sales (GAAP) | $11,851 | $10,978 | $873 | 8.0% | |||
Impact of Mexico joint venture sales | — | (207) | 207 | 2.0 | |||
Comparable sales excluding Mexico joint venture (Non-GAAP) | $11,851 | $10,771 | $1,080 | 10.0% | |||
Sales (GAAP) | $11,851 | $10,978 | $873 | 8.0% | |||
Impact of currency fluctuations (3) | (477) | (477) | (4.4) | ||||
Comparable sales using a constant currency basis (Non-GAAP) | $11,374 | $10,978 | $396 | 3.6% | |||
Gross profit (GAAP) | $2,492 | $2,262 | $230 | 10.2% | |||
Impact of currency fluctuations (3) | (114) | (114) | (5.1) | ||||
Comparable gross profit using a constant currency basis (Non- GAAP) | $2,378 | $2,262 | $116 | 5.1% | |||
Gross margin (GAAP) | 21.03% | 20.60% | 43 bps | ||||
Impact of currency fluctuations (3) | (0.12) | -12 bps | |||||
Comparable gross margin using a constant currency basis (Non- GAAP) | 20.91% | 20.60% | 31 bps | ||||
Operating expenses (GAAP) | $2,177 | $1,970 | $207 | 10.5% | |||
Impact of restructuring and transformational project costs (4) | (91) | (39) | (52) | NM | |||
Impact of acquisition-related costs (2) | (47) | (56) | 9 | 16.1 | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | 2,039 | 1,875 | 164 | 8.7 | |||
Impact of currency fluctuations (3) | (102) | (102) | (5.4) | ||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $1,937 | $1,875 | $62 | 3.3% | |||
Operating income (GAAP) | $315 | $292 | $23 | 7.9% | |||
Impact of restructuring and transformational project costs (4) | 91 | 39 | 52 | NM | |||
Impact of acquisition-related costs (2) | 47 | 56 | (9) | (16.1) | |||
Operating income adjusted for Certain Items (Non-GAAP) | 453 | 387 | 66 | 17.1 | |||
Impact of currency fluctuations (3) | (12) | (12) | (3.1) | ||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $441 | $387 | $54 | 14.0% | |||
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | %/bps Change | ||||
SYGMA | |||||||
Sales (GAAP) | $6,392 | $6,246 | $146 | 2.3% | |||
Gross profit (GAAP) | 496 | 492 | 4 | 0.8 | |||
Gross margin (GAAP) | 7.76% | 7.88% | -12 bps | ||||
Operating expenses (GAAP) | $432 | $438 | $(6) | (1.4)% | |||
Operating income (GAAP) | 64 | 54 | 10 | 18.5% | |||
OTHER | |||||||
Operating expenses (GAAP) | $185 | $188 | $(3) | (1.6)% | |||
Operating income (GAAP) | 17 | 9 | 8 | 88.9% | |||
GLOBAL SUPPORT CENTER | |||||||
Gross profit (GAAP) | $34 | $29 | $5 | 17.2% | |||
Operating expenses (GAAP) | $790 | $680 | $110 | 16.2% | |||
Impact of restructuring and transformational project costs (5) | (62) | (42) | (20) | (47.6) | |||
Impact of acquisition-related costs (6) | (36) | (12) | (24) | NM | |||
Operating expenses adjusted for Certain Items (Non-GAAP) | $692 | $626 | $66 | 10.5% | |||
Operating loss (GAAP) | $(756) | $(651) | $(105) | (16.1)% | |||
Impact of restructuring and transformational project costs (5) | 62 | 42 | 20 | 47.6 | |||
Impact of acquisition-related costs (6) | 36 | 12 | 24 | NM | |||
Operating loss adjusted for Certain Items (Non-GAAP) | $(658) | $(597) | $(61) | (10.2)% |
(1) | Primarily represents severance charges, transformation initiative costs, and costs associated with a legal matter. |
(2) | Fiscal 2026 and fiscal 2025 include intangible amortization expense and acquisition costs. |
(3) | Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results. |
(4) | Includes restructuring and transformation initiative costs primarily in Europe. |
(5) | Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy. |
(6) | Represents due diligence costs. |
NM | Represents that the percentage change is not meaningful. |
13-Week Period Ended Mar. 28, 2026 | 13-Week Period Ended Mar. 29, 2025 | Change in Dollars | % Change | ||||
Net earnings (GAAP) | $340 | $401 | $(61) | (15.2)% | |||
Interest (GAAP) | 168 | 149 | 19 | 12.8 | |||
Income taxes (GAAP) | 105 | 122 | (17) | (13.9) | |||
Depreciation and amortization (GAAP) | 251 | 238 | 13 | 5.5 | |||
EBITDA (Non-GAAP) | $864 | $910 | $(46) | (5.1)% | |||
Certain Item adjustments: | |||||||
Impact of restructuring, transformational project, and other costs (1) | $93 | $49 | $44 | 89.8% | |||
Impact of acquisition-related costs (2) | 13 | 10 | 3 | 30.0 | |||
EBITDA adjusted for Certain Items (Non-GAAP) (3) | $970 | $969 | $1 | 0.1% | |||
Other expense (income), net | 6 | 9 | (3) | (33.3) | |||
Depreciation and amortization, as adjusted (Non- GAAP) (4) | (208) | (205) | (3) | (1.5) | |||
Operating income adjusted for Certain Items (Non- GAAP) | $768 | $773 | $(5) | (0.6)% |
(1) | Fiscal 2026 and fiscal 2025 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy, excluding charges related to accelerated depreciation. In addition, fiscal 2026 includes charges associated with a legal matter. |
(2) | Fiscal 2026 and fiscal 2025 include acquisition and due diligence costs. |
(3) | In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $6 million and $7 million or non-cash stock compensation expense of $31 million and $15 million in fiscal 2026 and fiscal 2025, respectively. |
(4) | Fiscal 2026 includes $251 million in GAAP depreciation and amortization expense, less $43 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. Fiscal 2025 includes $238 million in GAAP depreciation and amortization expense, less $33 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. |
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | Change in Dollars | % Change | ||||
Net earnings (GAAP) | $1,206 | $1,297 | $(91) | (7.0)% | |||
Interest (GAAP) | 512 | 469 | 43 | 9.2 | |||
Income taxes (GAAP) | 350 | 402 | (52) | (12.9) | |||
Depreciation and amortization (GAAP) | 724 | 709 | 15 | 2.1 | |||
EBITDA (Non-GAAP) | $2,792 | $2,877 | $(85) | (3.0)% | |||
Certain Item adjustments: | |||||||
Impact of restructuring, transformational project, and other costs (1) | $203 | $104 | $99 | 95.2% | |||
Impact of acquisition-related costs (2) | 46 | 24 | 22 | 91.7 | |||
EBITDA adjusted for Certain Items (Non-GAAP) (3) | $3,041 | $3,005 | $36 | 1.2% | |||
Other expense (income), net | 44 | 32 | 12 | 37.5 | |||
Depreciation and amortization, as adjusted (Non- GAAP) (4) | (611) | (609) | (2) | (0.3) | |||
Operating income adjusted for Certain Items (Non- GAAP) | $2,474 | $2,428 | $46 | 1.9% |
(1) | Fiscal 2026 and 2025 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy, excluding charges related to accelerated depreciation. In addition, fiscal 2026 includes charges associated with a legal matter. |
(2) | Fiscal 2026 and fiscal 2025 include acquisition and due diligence costs. |
(3) | In arriving at adjusted EBITDA, Sysco does not exclude interest income of $18 million and $22 million or non-cash stock compensation expense of $95 million and $74 million for fiscal 2026 and fiscal 2025, respectively. |
(4) | Fiscal 2026 includes $724 million in GAAP depreciation and amortization expense, less $113 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. Fiscal 2025 includes $709 million in GAAP depreciation and amortization expense, less $100 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. |
39-Week Period Ended Mar. 28, 2026 | 39-Week Period Ended Mar. 29, 2025 | ||
Source of cash (use of cash) | (In millions) | ||
Net cash provided by operating activities (GAAP) | $1,463 | $1,317 | |
Additions to plant and equipment | (461) | (532) | |
Proceeds from sales of plant and equipment | 131 | 169 | |
Free Cash Flow (Non-GAAP) (1) | $1,133 | $954 | |
Acquisition of businesses, net of cash acquired | $(189) | $(40) | |
Debt borrowings (repayments), net | 637 | 1,078 | |
Stock repurchases | (200) | (700) | |
Dividends paid | (778) | (752) | |
(1) | Free cash flow should not be used as a substitute for the most comparable GAAP measure in assessing the company’s liquidity for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Key Performance Indicators” contained in our fiscal 2025 Form 10-K for discussions regarding this non-GAAP performance metric. |
Combined Parent and Guarantor Subsidiaries Summarized Balance Sheet | Mar. 28, 2026 | Jun. 28, 2025 | ||
(In millions) | ||||
ASSETS | ||||
Receivables due from non-obligor subsidiaries | $157 | $377 | ||
Current assets | 7,296 | 6,015 | ||
Total current assets | $7,453 | $6,392 | ||
Notes receivable from non-obligor subsidiaries | $1 | $20 | ||
Other noncurrent assets | 5,410 | 5,211 | ||
Total noncurrent assets | $5,411 | $5,231 | ||
LIABILITIES | ||||
Payables due to non-obligor subsidiaries | $83 | $61 | ||
Other current liabilities | 3,512 | 3,214 | ||
Total current liabilities | $3,595 | $3,275 | ||
Notes payable to non-obligor subsidiaries | $406 | $334 | ||
Long-term debt | 12,139 | 11,890 | ||
Other noncurrent liabilities | 1,764 | 1,538 | ||
Total noncurrent liabilities | $14,309 | $13,762 | ||
Combined Parent and Guarantor Subsidiaries Summarized Results of Operations | 39-Week Period Ended Mar. 28, 2026 | |
(In millions) | ||
Sales | $37,632 | |
Gross profit | 6,719 | |
Operating income | 1,599 | |
Interest expense from non-obligor subsidiaries | 111 | |
Net earnings | 956 | |
ISSUER PURCHASES OF EQUITY SECURITIES | |||||||
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2) | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | |||
Month #1 | |||||||
December 28 - January 24 | — | $— | — | — | |||
Month #2 | |||||||
January 25 - February 21 | 1,918,075 | 89.64 | 1,912,374 | — | |||
Month #3 | |||||||
February 22 - March 28 | 318,041 | 89.84 | 318,041 | — | |||
Totals | 2,236,116 | $89.66 | 2,230,415 | — | |||
(1) | The total number of shares purchased includes 0, 5,701, and 0 shares tendered by individuals in connection with stock option exercises in Month #1, Month #2 and Month #3, respectively. |
(2) | See the discussion in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Equity Transactions” for additional information regarding Sysco’s share repurchase program. |
2.1** | — | Agreement and Plan of Merger, dated as of March 30, 2026, by and among Sysco Corporation, JRD Unico, Inc., Warehouse Realty, LLC, New Slider Holdco, Inc., Slider Merger Sub 1, Inc., Slider Merger Sub 2, Inc., Slider Merger Sub 3, LLC, and Holder Representative, incorporated by reference to Exhibit 2.1 to the current report on Form 8-K filed on March 30, 2026 (File No. 1-6544). |
3.1 | — | Restated Certificate of Incorporation, incorporated by reference to Exhibit 3(a) to Form 10-K for the year ended June 28, 1997 (File No. 1-6544). |
3.2 | — | Certificate of Amendment to Restated Certificate of Incorporation increasing authorized shares, incorporated by reference to Exhibit 3(e) to Form 10-Q for the quarter ended December 27, 2003 (File No. 1-6544). |
3.3 | — | Form of Amended Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock, incorporated by reference to Exhibit 3(c) to Form 10-K for the year ended June 29, 1996 (File No. 1-6544). |
3.4 | — | Amended and Restated Bylaws of Sysco Corporation dated June 20, 2024, incorporated by reference to Exhibit 4.4 to the Form S-8 filed on December 6, 2024 (File No. 1-6544). |
4.1 | — | Forty-Eighth Supplemental Indenture, dated as of February 13, 2026, by and among the Company, the Subsidiary Guarantors and the Trustee relating to the 2031 Notes (including the Form of 4.400% Senior Note), incorporated by reference to Exhibit 4.1 to the current report on Form 8-K filed on February 13, 2026 (File No. 1-6544). |
4.2 | — | Forty-Ninth Supplemental Indenture, dated as of February 13, 2026, by and among the Company, the Subsidiary Guarantors and the Trustee relating to the 2036 Notes (including the Form of 4.950% Senior Note), incorporated by reference to Exhibit 4.2 to the current report on Form 8-K filed on February 13, 2026 (File No. 1-6544). |
10.1** | — | Stockholders Agreement, dated as of March 30, 2026, by and among New Slider Holdco, Inc and certain other parties thereto, incorporated by reference to Exhibit 10.1 to the current report on Form 8-K filed on March 30, 2026 (File No. 1-6544). |
22.1# | — | Subsidiary Guarantors and Issuers of Guaranteed Securities. |
31.1# | — | CEO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2# | — | CFO Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32.1* | — | CEO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
32.2* | — | CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
101.SCH# | — | Inline XBRL Taxonomy Extension Schema Document |
101.CAL# | — | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF# | — | Inline XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB# | — | Inline XBRL Taxonomy Extension Labels Linkbase Document |
101.PRE# | — | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
104 | — | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Sysco Corporation | ||
(Registrant) | ||
Date: April 28, 2026 | By: | /s/ KEVIN P. HOURICAN |
Kevin P. Hourican | ||
Chair of the Board and | ||
Chief Executive Officer | ||
Date: April 28, 2026 | By: | /s/ BRANDON SEWELL |
Brandon Sewell | ||
Interim Chief Financial Officer | ||
Date: April 28, 2026 | By: | /s/ JENNIFER L. JOHNSON |
Jennifer L. Johnson | ||
Senior Vice President, | ||
Chief Accounting Officer |